Biomarkers Assays and Validation
Intertek has validated a select number of assays for biomarkers used in GLP-compliant preclinical and clinical development programs.
Assays for biomarkers can be very useful in the selection of a lead compound, determining the mechanism of action of a drug, as a surrogate marker for monitoring clinical efficacy, or for identifying intermediate endpoints of success to decrease follow-up time for a specific treatment. The potential for a specific biomarker assay in a blood sample to give an early indication of drug efficacy can assist both with reducing attrition rates and optimizing clinical development programs.
Industry-leading scientific expertise includes developing and validating biomarkers in single or multiplex assay formats utilizing prototype and commercially available such as Meso Scale Discovery (MSD) multiplex technology.
Related Biomarker Services
Request more information to see how Intertek can help your organization with Biomarkers Assays and Validation.